** Australia-listed shares of a2 Milk A2M.AX down 0.7% at A$8.47
** Citi says food tech firm Clover's strong 1H25 results suggests positive near-term outlook for infant formula sector
** Clover, an infant formula ingredient supplier, logs HY net profit after tax A$2.4 million ($1.53 million) vs loss A$0.6 mln last year
** Citi flags recovery of infant formula business in Europe and ANZ in Clover's results
** A2's execution has been strong in recent years when the birth rate was declining and domestic brands were taking share; both of those headwinds have now turned to tailwinds - Citi
** Citi also expects new market gains for a2 Milk as co accelerates new product development
** Brokerage maintains "Buy" rating and price target A$8.2
** Stock up 46.5% YTD, including current session's moves
($1 = 1.5723 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。